---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-26-003429"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2026-07-07T20:30:21+00:00"
generated_at: "2026-07-07T20:31:13.977881+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lifeward issues $5.58M initial convertible notes; additional $5.58M contingent on milestones

## Summary
- Initial $5.58M senior secured convertible notes at 8% interest, convertible at $5.40/share.
- Additional $5.58M notes require 150% ReWalk unit sales growth or stock price ≥$13.80 for 10 days.
- Warrants for 100% of conversion shares at $5.40 exercise price, 5-year term.
- Beneficial ownership limited to 4.99%; exchange cap at 19.99% unless shareholder approval.
- Oramed Pharmaceuticals acts as collateral agent for the transaction.

## SEC filing metadata
- accession: 0001178913-26-003429
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2026-07-07T20:30:21+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891326003429/0001178913-26-003429-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891326003429/zk2635657.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-26-003429
- JSON: https://secwatch.observer/filing/0001178913-26-003429.json
- Plain text: https://secwatch.observer/filing/0001178913-26-003429.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.